We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Ryan Pincura, Director of Regulatory Affairs, Tendrel Group
Webinar

The Challenges of Psilocybin Legal Licensing and Compliance

On-Demand
Join us for an exclusive webinar focused on psilocybin licensing and compliance with expert speaker Ryan Pincura, Director of Regulatory Affairs at Tendrel Group.
Webinar

A Little Too Loud: Cutting Through the Noise in Your Journey to a Digital Lab

On-Demand
Attend this webinar to learn how to:
- Create a “digital thread” from the data elements needed for a digital lab
- Connect, develop and understand the context of the data elements to weave a “digital fabric”
- Transform your “digital fabric” into actionable insights for your journey to a digital lab
Webinar

Assessing mRNA and LNP Quality Attributes and Impurities

On-Demand
Detailed and sensitive characterization of ionizable lipids that make up lipid nanoparticles (LNP) and their related impurities is necessary to ensure the quality of mRNA therapies. Additionally, there are mRNA quality attributes such as 5’ capping that directly impact efficacy and safety.
Webinar

Level Up Your LNP Making Skills With Nunchuck

On-Demand
The Problem
LNPs are a valuable tool in the repertoire of gene and vaccine delivery vectors but LNP development is a complex multi-step process.
Webinar

Novel Chemical Entities in Psychedelics: Risks and Rewards for Investors

On-Demand
Join us for an exclusive panel discussion focused on research and development relating to novel chemical entities in the psychedelics industry and some of the viable business models that are emerging in this field.
Webinar

Looking to the Future of Cell and Gene Therapies

On-Demand
This Technology Networks event features exclusive talks focused on the most recent and innovative developments in the world of cell and gene therapies. Our expert speakers will highlight the opportunities cell and gene therapies provide for the treatment of disease and injury, including how cell therapies are providing novel solutions for rare diseases such as Duchenne muscular dystrophy.
Advertisement